JP2015036367A5 - - Google Patents

Download PDF

Info

Publication number
JP2015036367A5
JP2015036367A5 JP2013167197A JP2013167197A JP2015036367A5 JP 2015036367 A5 JP2015036367 A5 JP 2015036367A5 JP 2013167197 A JP2013167197 A JP 2013167197A JP 2013167197 A JP2013167197 A JP 2013167197A JP 2015036367 A5 JP2015036367 A5 JP 2015036367A5
Authority
JP
Japan
Prior art keywords
composition
enhancing
estrogen
estrogen secretion
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013167197A
Other languages
English (en)
Japanese (ja)
Other versions
JP5923468B2 (ja
JP2015036367A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013167197A priority Critical patent/JP5923468B2/ja
Priority claimed from JP2013167197A external-priority patent/JP5923468B2/ja
Priority to PCT/JP2014/068675 priority patent/WO2015022830A1/ja
Publication of JP2015036367A publication Critical patent/JP2015036367A/ja
Publication of JP2015036367A5 publication Critical patent/JP2015036367A5/ja
Application granted granted Critical
Publication of JP5923468B2 publication Critical patent/JP5923468B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013167197A 2013-08-10 2013-08-10 エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。 Active JP5923468B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2013167197A JP5923468B2 (ja) 2013-08-10 2013-08-10 エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。
PCT/JP2014/068675 WO2015022830A1 (ja) 2013-08-10 2014-07-14 エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013167197A JP5923468B2 (ja) 2013-08-10 2013-08-10 エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。

Publications (3)

Publication Number Publication Date
JP2015036367A JP2015036367A (ja) 2015-02-23
JP2015036367A5 true JP2015036367A5 (es) 2015-06-25
JP5923468B2 JP5923468B2 (ja) 2016-05-24

Family

ID=52468220

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013167197A Active JP5923468B2 (ja) 2013-08-10 2013-08-10 エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。

Country Status (2)

Country Link
JP (1) JP5923468B2 (es)
WO (1) WO2015022830A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5923468B2 (ja) * 2013-08-10 2016-05-24 株式会社マザー&チャイルド エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。
JP2018104378A (ja) * 2016-12-27 2018-07-05 株式会社マザー&チャイルド 女性月経周期における各月経ステージに対応する集中力向上・衝動性低下の作用を有する芳香用組成物。

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011152007A1 (ja) * 2010-05-31 2011-12-08 株式会社資生堂 交感神経抑制剤及び皮膚温度低下剤並びにそれを含有する化粧料、食品、及び雑貨
JP5923468B2 (ja) * 2013-08-10 2016-05-24 株式会社マザー&チャイルド エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。

Similar Documents

Publication Publication Date Title
PH12016500094A1 (en) Autotaxin inhibitors
WO2015018380A3 (en) Therapeutic nanoparticles and the preparation methods thereof
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
WO2014205302A3 (en) Lectin-like oxidized ldl receptor1 antibodies and methods of use
EP3613419A4 (en) PHARMACEUTICAL COMPOSITION WITH INDIRUBY DERIVATIVE AS THE ACTIVE SUBSTANCE
WO2014205300A3 (en) Lectin-like oxidized ldl receptor1 antibodies and methods of use
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
WO2013150529A3 (en) Indole, indoline derivatives, compositions comprising them and uses thereof
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016001422A (es) Composicion farmaceutica de fingolimod.
WO2015092810A3 (en) Amorphous form of idelalisib
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
JP2015036367A5 (es)
WO2011145851A3 (ko) 사이프러스 에센셜 복합 오일을 유효 성분으로 함유하는 기억력 증진 및 인지 기능 장애 개선을 위한 화장료 조성물
WO2014056851A3 (en) Flavor and fragrance formulation (i)
IN2015DN02645A (es)
PH12019500024A1 (en) Pharmaceutical compositions
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
MA20150350A1 (fr) Dérivés isoxazolidine
BR112018074538A2 (pt) composto, método para preparar compostos, uso de compostos, composição de substância aromatizante e/ou fragrância, produto perfumado ou aromatizado, e, método para perfumar um produto.
JP2015036368A5 (es)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
WO2015022315A3 (de) Deodorant- und/oder antitranspirantzubereitungen umfassend polyzyklische michael-akzeptoren